ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

FDMT 4D Molecular Therapeutics Inc

26.41
1.02 (4.02%)
最終更新日: 04:15:46
15分遅延
名称 銘柄コード 市場 種別
4D Molecular Therapeutics Inc FDMT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.02 4.02% 26.41 04:15:46
始値 安値 高値 終値 前日終値
25.31 24.93 26.50 25.39
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0121:00GLOBE4DMT Announces Presentations at ARVO 2024 Annual Meeting
2024/3/2821:00GLOBE4DMT Announces Update on Regulatory Interactions and..
2024/3/0422:00GLOBE4DMT to Participate in Upcoming Investor Conferences
2024/3/0108:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0106:12EDGAR2Form 8-K - Current report
2024/3/0106:05GLOBE4DMT Reports Full Year 2023 Financial Results and..
2024/2/2207:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1510:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1311:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1310:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1222:00GLOBE4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2..
2024/2/1006:56EDGAR2Form 8-K - Current report
2024/2/0906:50EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0906:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0906:22EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0810:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0809:42EDGAR2Form 3/A - Initial statement of beneficial ownership of..
2024/2/0713:27GLOBE4D Molecular Therapeutics Announces Pricing of Upsized..
2024/2/0607:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0606:35EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/0606:05GLOBE4D Molecular Therapeutics Announces Proposed Public Offering..
2024/2/0407:00GLOBE4DMT Presents Positive Interim Data from Randomized Phase 2..
2024/1/2922:00GLOBE4DMT to Host Corporate Webcast to Discuss Interim Data from..
2024/1/2606:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2406:50EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2322:00GLOBE4DMT Receives Rare Pediatric Disease Designation from FDA..
2024/1/0906:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:49EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0507:48EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0422:30EDGAR2Form 8-K - Current report
2024/1/0422:00GLOBE4DMT Highlights Recent Clinical Pipeline Progress, Near-Term..
2024/1/0322:01GLOBE4DMT and Arbor Biotechnologies Establish Partnership to..
2023/12/2202:31DJN4D Molecular Shares Rise on FDA Designation for Wet AMD Drug
2023/12/2122:00GLOBE4DMT Receives FDA Regenerative Medicine Advanced Therapy..
2023/12/1907:16EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1607:24EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0422:00GLOBE4DMT to Present Interim 24 Week Data from Randomized Phase 2..
2023/11/2306:20EDGAR2Form 8-K - Current report
2023/11/1522:00GLOBE4DMT to Participate in Upcoming Investor Conferences
2023/11/1006:23EDGAR2Form 8-K - Current report
2023/11/1006:19GLOBE4DMT Reports Third Quarter 2023 Financial Results and..
2023/11/0205:00GLOBE4DMT Presents Positive Interim Data from Phase 1/2 AEROW..

最近閲覧した銘柄

Delayed Upgrade Clock